Search by Drug Name or NDC

    NDC 67457-0855-02 adenosine 3 mg/mL Details

    adenosine 3 mg/mL

    adenosine is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Mylan Institutional LLC. The primary component is ADENOSINE.

    Product Information

    NDC 67457-0855
    Product ID 67457-855_7710afdc-4172-4424-b36b-f33b41896aa6
    Associated GPIs 35500010002015
    GCN Sequence Number 013630
    GCN Sequence Number Description adenosine VIAL 3 MG/ML INTRAVEN
    HIC3 A2A
    HIC3 Description ANTIARRHYTHMICS
    GCN 35350
    HICL Sequence Number 003734
    HICL Sequence Number Description ADENOSINE
    Brand/Generic Generic
    Proprietary Name adenosine
    Proprietary Name Suffix n/a
    Non-Proprietary Name adenosine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAVENOUS
    Active Ingredient Strength 3
    Active Ingredient Units mg/mL
    Substance Name ADENOSINE
    Labeler Name Mylan Institutional LLC
    Pharmaceutical Class Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA078686
    Listing Certified Through 2024-12-31

    Package

    NDC 67457-0855-02 (67457085502)

    NDC Package Code 67457-855-02
    Billing NDC 67457085502
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (67457-855-02) / 2 mL in 1 VIAL, SINGLE-DOSE (67457-855-00)
    Marketing Start Date 2018-05-08
    NDC Exclude Flag N
    Pricing Information N/A